Zoliflodacin 8317 4ClH/c1-19(45-49-31(35)36)23-13-24(20(2)46-50-32(37)38)16-27(15-23)43-29(53)11-9-7-5-6-8-10-12-30(54)44-28-17-25(21(3)47-51-33(39)40)14-26(18-28)22(4)48-52-34(41)42

4ClH/c1-19(45-49-31(35)36)23-13-24(20(2)46-50-32(37)38)16-27(15-23)43-29(53)11-9-7-5-6-8-10-12-30(54)44-28-17-25(21(3)47-51-33(39)40)14-26(18-28)22(4)48-52-34(41)42

3-benzoxazol-2-amine

39(1):267-76

another group of rats treated with 600 μmol/kg of compound are allowed to recover for 14 days

1-alpha]isoquinolin-4-one

Zoliflodacin 8317 4ClH/c1-19(45-49-31(35)36)23-13-24(20(2)46-50-32(37)38)16-27(15-23)43-29(53)11-9-7-5-6-8-10-12-30(54)44-28-17-25(21(3)47-51-33(39)40)14-26(18-28)22(4)48-52-34(41)42Zoliflodacin (ETX0914; AZD0914) is a novel spiropyrimidinetrione bacterial DNA gyrase topoisomerase inhibitor. Zoliflodacin has potent in vitro antibacterial activity against Gram positive and Gram negative organisms, including S. aureus with the MIC90 of 0. 25 g mL. Product information CAS Number: 1620458 09 4 Molecular Weight: 487. 44 Formula: C22H22FN5O7 Chemical Name: (4'R,6'S,7'S) 17' fluoro 4',6' dimethyl 13' [(4S) 4 methyl 2 oxo 1,3 oxazolidin